Urolog. pro Praxi, 2008; 9(3): 112-115

Pain treatment in interstitial cystitis

MUDr. Pavlína Nosková
Centrum léčby bolesti KARIM VFN a 1. LF UK, Praha

Interstitial cystitis is a chronic non-bacterial inflammatory disorder of the bladder wall manifestating with pain, urgency and frequent miction. Pain predominates in hypogastrium with engagement of small pelvis, sacrum, perineum, genital tract, groins and thighs typically. This is basicaly mixed pain in terms of patophysiology, being descripted as nociceptive visceral pain predominantly with neuropatic component. With knowledge like this we are able to choose the right pharmacology class with optimal influence on pain. Multidisciplinary access to the patient is unnecessary anyway, mainly cooperation among the urologist, algeziologist and psychiatrist is requiered.

Keywords: interstitial cystitis, painful bladder syndrome, chronic pain, neuropatic pain, adjuvant analgetics

Published: June 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Nosková P. Pain treatment in interstitial cystitis. Urol. praxi. 2008;9(3):112-115.
Download citation

References

  1. Ambler Z, Bednařík J, Keller O. Doporučený postup pro léčbu neuropatické bolesti. www.pain.cz
  2. Bednařík J, Ambler Z. Doporučení EFNS pro farmakologickou léčbu neuropatické bolesti. čas. Bolest - suppl. 2007; 10(1): 26.
  3. Dimitrakov J, Kroenke K, Steers WD, Berde C, Zurakowski D, Freeman MR, Jackson JL. Pharmacologic management of PBS/IC. Arch Inter Med. 2007; 167(18): 1922-1929. Go to original source... Go to PubMed...
  4. Dworkin RH, et al. Pregabalin for the treatment of postherpetic neuralgia. A randomized, placebo-controlled trial. Neurology 2003; 60: 1274-1283. Go to original source... Go to PubMed...
  5. Freynhagena R, et al. Efficacy of pregabalin in neuropathic pain avaluated in a 12 week, randomised, double-blind, multicenter, placebo-controlled trial of flexible and fixed dose regimens. Pain 2005; 116: 109-118. Go to original source... Go to PubMed...
  6. Hamman W, et al. Pulsed radiofrequecy applied to dorsal root ganglia causes a selective increase in ATF3 small neurons. Eur J. Pain 2005. Go to original source... Go to PubMed...
  7. Hanuš T, Zámečník L. Intersticiální cystitida. Nucleus HK 2007: 6-52.
  8. Kršiak M. Farmakoterapie bolestí zad. Bolest 2007; 10(1): 14.
  9. Lauterburg BH. Analgesics and glutathione. Am. J. Ther. 2002; 9: 225-233. Go to original source... Go to PubMed...
  10. Michálek P, Gabrhelík T. Pulsní radiofrekvenční léčba-nová alternativa na poli neuromodulace?. Bolest 2005; 8(4): 217-221.
  11. Rokyta R, Kršiak M, Kozák J. Bolest. TIGIS 2006: 226-231.
  12. Rokyta R. Patofyziologie bolesti. Postgraduální medicína 2003; 5(1): 51-54.
  13. Rosenstock J, et al. Pregabalin for the treatment of painful diabetic peripharal neuropathy: a double blind, placebo-controlled trial. Pain 2004; 110: 628-638. Go to original source... Go to PubMed...
  14. Rowbotham M, et al. Gabapentin for the treatment of postherpetic neuralgia. A randomized controlled trial. JAMA 1998; 280: 1837-1842. Go to original source... Go to PubMed...
  15. Sabatowskia R, et al. Pregabalin reduces pain and improves sleep and mood distrurbances patients with postherpetic neuralgia: Pain 2004; 109: 26-35.
  16. Serpell MG. Neuropathic pain study group. Gabapentin in neuropathic pain syndromes: results of a randomised, placebo controlled trial. Pain 2002; 99: 557-566. Go to original source... Go to PubMed...
  17. Shahani R, Streuker C, Dickson B, Stewart RJ. Ketamine-associated ulcerative cystitis. Urology, 2007; 69(5): 810-812. Go to original source... Go to PubMed...
  18. Steinberg AC, Oyama IA, Whitmore KE. Bilateral S3 stimulator in patients with interstitial cystitis. Urology. 2007; 69(3): 441-443. Go to original source... Go to PubMed...
  19. Zámečník L. Chronická bolest u intersticiální cystitidy. Urol. Listy 2007; 5(2): 41-47.
  20. Zámečník L. Intersticiální cystitida. Praha 2007: 4-50 (v tisku).




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.